Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin | Patent Number 06455518

US 06455518 B2
Application Number9758301
Publication NumberUS 20010008888 A1
Pendency1 year, 8 months, 16 days
Filled DateJan 11, 2001
Priority DateJul 29, 1997
Publication DateJul 19, 2001
Expiration DateJul 29, 2017
Inventor/ApplicantsBarbara Haeberlin
Armin Meinzer
Barbara Haeberlin
Hendrik Schuurman
Gerhard Zenke
Gerhard Zenke
Hendrik Schuurman
Armin Meinzer
ExaminesWEDDINGTON, KEVIN E
Art Unit1614
Technology Center1600
Assignments
Novartis
Current
Novartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.